BioMimetic Therapeutics, Inc. Release: Presentations from the Regenerative Strategies and Emerging Technologies Forum at the American Orthopaedic Foot & Ankle Society (AOFAS) Meeting
FRANKLIN, Tenn.--(BUSINESS WIRE)--Numerous presentations were made today during the Regenerative Strategies Forum at the 2012 American Orthopaedic Foot and Ankle Society (AOFAS) annual meeting in San Diego, CA which supported the safety, effectiveness, clinical need, biologic rationale and cost effectiveness of Augment™ Bone Graft from BioMimetic Therapeutics, Inc. (NASDAQ: BMTI).